mRNA vaccines encoding computationally optimized hemagglutinin elicit protective antibodies against future antigenically drifted H1N1 and H3N2 influenza viruses isolated between 2018-2020
BackgroundThe implementation of mRNA vaccines against COVID-19 has successfully validated the safety and efficacy of the platform, while at the same time revealing the potential for their applications against other infectious diseases. Traditional seasonal influenza vaccines often induce strain spec...
Main Authors: | James D. Allen, Ted M. Ross |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2024-03-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2024.1334670/full |
Similar Items
-
Evaluation of Pre-Pandemic Trivalent COBRA HA Vaccine in Mice Pre-Immune to Historical H1N1 and H3N2 Influenza Viruses
by: Pan Ge, et al.
Published: (2023-01-01) -
Next Generation of Computationally Optimized Broadly Reactive HA Vaccines Elicited Cross-Reactive Immune Responses and Provided Protection against H1N1 Virus Infection
by: Ying Huang, et al.
Published: (2021-07-01) -
Construction of an mRNA vaccine encoding hemagglutinin of influenza A H1N1
virus and investigation on booster immunization strategy
by: SHEN Haiqian, et al.
Published: (2023-11-01) -
H3N2 influenza viruses in humans: Viral mechanisms, evolution, and evaluation
by: James D. Allen, et al.
Published: (2018-08-01) -
Development of an mRNA vaccine against a panel of heterologous H1N1 seasonal influenza viruses using a consensus hemagglutinin sequence
by: Ning Ma, et al.
Published: (2023-12-01)